BK virus infection in transplant recipients: Clinical manifestations, treatment options and the immune response

Netherlands Journal of Medicine

Volumn 70, Issue 4, 2012, Pages 172-183

  Van Aalderen, M C ^a,c   Heutinck, K M ^a,c   Huisman, C ^b   ten Berge, I J M ^a  

^a Renal Transplant Unit   (Netherlands)

^b Division of Internal Medicine ^*  (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Haemorrhagic cystitis; Nephropathy; Polyomavirus BK; Ureteral stenosis; Viral immunity

Indexed keywords

CIDOFOVIR; CIPROFLOXACIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN; LEFLUNOMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; QUINOLINE DERIVED ANTIINFECTIVE AGENT; T LYMPHOCYTE ANTIBODY; TACROLIMUS;

BK VIRUS; BK VIRUS INFECTION; CLINICAL FEATURE; GRAFT FAILURE; GRAFT RECIPIENT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYTIC ANEMIA; HEMORRHAGIC CYSTITIS; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPROMISED PATIENT; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LIFE CYCLE; NEPHROTOXICITY; NONHUMAN; REVIEW; SIDE EFFECT; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT PLANNING; URETER OBSTRUCTION; UVEITIS; VIRUS CARCINOGENESIS; VIRUS LOAD; VIRUS MORPHOLOGY; VIRUS REACTIVATION; VIRUS REPLICATION;

BK VIRUS; CYSTITIS; HEMORRHAGE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; URETERAL OBSTRUCTION;

EID: 84862527155     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (190)

1. Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet. 1971 Jun 19;1(7712):1253-7.
2. Shah KV, Daniel RW, Warszawski RM. High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. J Infect Dis. 1973 Dec;128(6):784-7.
3. Portolani M, Marzocchi A, Barbanti-Brodano G, La Placa M. Prevalence in Italy of antibodies to a new human papovavirus (BK virus). J Med Microbiol. 1974 Nov;7(4):543-6.
4. Yang RC, Wu R. BK virus DNA: complete nucleotide sequence of a human tumor virus. Science. 1979 Oct 26;206(4417):456-62.
5. Seif I, Khoury G, Dhar R. The genome of human papovavirus BKV. Cell. 1979 Dec;18(4):963-77.
6. Dhar R, Lai CJ, Khoury G. Nucleotide sequence of the DNA replication origin for human papovavirus BKV: sequence and structural homology with SV40. Cell. 1978 Feb;13(2):345-58.
7. Frisque RJ, Bream GL, Cannella MT. Human polyomavirus JC virus genome. J Virol. 1984 Aug;51(2):458-69.
8. Seehafer J, Salmi A, Scraba DG, Colter JS. A comparative study of BK and polyoma viruses. Virology. 1975 Jul;66(1):192-205.
9. Chen XS, Stehle T, Harrison SC. Interaction of polyomavirus internal protein VP2 with the major capsid protein VP1 and implications for participation of VP2 in viral entry. EMBO J. 1998 Jun 15;17(12):3233-40.
10. Clever J, Dean DA, Kasamatsu H. Identification of a DNA binding domain in simian virus 40 capsid proteins Vp2 and Vp3. J Biol Chem. 1993 Oct 5;268(28):20877-83.
11. Dugan AS, Gasparovic ML, Tsomaia N, et al. Identification of amino acid residues in BK virus VP1 that are critical for viability and growth. J Virol. 2007 Nov;81(21):11798-808.
12. Dugan AS, Eash S, Atwood WJ. An N-linked glycoprotein with alpha(2,3)-linked sialic acid is a receptor for BK virus. J Virol. 2005 Nov;79(22):14442-5.
13. Low JA, Magnuson B, Tsai B, Imperiale MJ. Identification of gangliosides GD1b and GT1b as receptors for BK virus. J Virol. 2006 Feb;80(3):1361-6.
14. Eash S, Querbes W, Atwood WJ. Infection of vero cells by BK virus is dependent on caveolae. J Virol. 2004 Nov;78(21):11583-90.
15. Singh RD, Marks DL, Holicky EL, et al. Gangliosides and beta1-integrin are required for caveolae and membrane domains. Traffic. 2010 Mar;11(3):348-60.
16. Moriyama T, Sorokin A. Intracellular trafficking pathway of BK Virus in human renal proximal tubular epithelial cells. Virology. 2008 Feb. 20;371(2):336-49.
17. Jiang M, Abend JR, Tsai B, Imperiale MJ. Early events during BK virus entry and disassembly. J Virol. 2009 Feb;83(3):1350-8.
18. Nakanishi A, Itoh N, Li PP, Handa H, Liddington RC, Kasamatsu H. Minor capsid proteins of simian virus 40 are dispensable for nucleocapsid assembly and cell entry but are required for nuclear entry of the viral genome. J Virol. 2007 Apr;81(8):3778-85.
19. Fang CY, Chen HY, Wang M, et al. Global analysis of modifications of the human BK virus structural proteins by LC-MS/MS. Virology. 2010 Jun 20;402(1):164-76.
20. Deyerle KL, Subramani S. Linker scan analysis of the early regulatory region of human papovavirus BK. J Virol. 1988 Sep;62(9):3378-87.
21. Gorrill TS, Khalili K. Cooperative interaction of p65 and C/EBPbeta modulates transcription of BKV early promoter. Virology. 2005 Apr 25;335(1):1-9.
22. Mastrangelo IA, Hough PV, Wall JS, Dodson M, Dean FB, Hurwitz J. ATP-dependent assembly of double hexamers of SV40 T antigen at the viral origin of DNA replication. Nature. 1989 Apr 20;338(6217):658-62.
23. Wang W, Simmons DT. Simian virus 40 large T antigen can specifically unwind the central palindrome at the origin of DNA replication. J Virol. 2009 Apr;83(7):3312-22.
24. Kelley WL, Georgopoulos C. The T/t common exon of simian virus 40, JC, and BK polyomavirus T antigens can functionally replace the J-domain of the Escherichia coli DnaJ molecular chaperone. Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3679-84.
25. Dyson N, Bernards R, Friend SH, et al. Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein. J Virol. 1990 Mar;64(3):1353-6.
26. Bollag B, Chuke WF, Frisque RJ. Hybrid genomes of the polyomaviruses JC virus, BK virus, and simian virus 40: identification of sequences important for efficient transformation. J Virol. 1989 Feb;63(2):863-72.
27. Berger H, Wintersberger E. Polyomavirus small T antigen enhances replication of viral genomes in 3T6 mouse fibroblasts. J Virol. 1986 Nov;60(2):768-70.
28. Klucky B, Wintersberger E. Polyomavirus small T antigen transactivates genes by its ability to provoke the synthesis and the stabilization of MYC. Oncogene. 2007 Sep 20;26(43):6356-60.
29. Abend JR, Joseph AE, Das D, Campbell-Cecen DB, Imperiale MJ. A truncated T antigen expressed from an alternatively spliced BK virus early mRNA. J Gen Virol. 2009 May;90(Pt 5):1238-45.
30. Myhre MR, Olsen GH, Gosert R, Hirsch HH, Rinaldo CH. Clinical polyomavirus BK variants with agnogene deletion are non-functional but rescued by trans-complementation. Virology. 2010 Mar 1;398(1):12-20.
31. Darbinyan A, Siddiqui KM, Slonina D, et al. Role of JC virus agnoprotein in DNA repair. J Virol. 2004 Aug;78(16):8593-600.
32. Drachenberg CB, Papadimitriou JC, Wali R, Cubitt CL, Ramos E. BK polyoma virus allograft nephropathy: ultrastructural features from viral cell entry to lysis. Am J Transplant. 2003 Nov;3(11):1383-92.
33. Low J, Humes HD, Szczypka M, Imperiale M. BKV and SV40 infection of human kidney tubular epithelial cells in vitro. Virology. 2004 Jun 1;323(2):182-8.
34. Jeffers LK, Madden V, Webster-Cyriaque J. BK virus has tropism for human salivary gland cells in vitro: implications for transmission. Virology. 2009 Nov 25;394(2):183-93.
35. Vanchiere JA, Abudayyeh S, Copeland CM, Lu LB, Graham DY, Butel JS. Polyomavirus shedding in the stool of healthy adults. J Clin Microbiol. 2009 Aug;47(8):2388-91.
36. Boldorini R, Allegrini S, Miglio U, et al. BK virus sequences in specimens from aborted fetuses. J Med Virol. 2010 Dec;82(12):2127-32.
37. Dugan AS, Maginnis MS, Jordan JA, et al. Human alpha-defensins inhibit BK virus infection by aggregating virions and blocking binding to host cells. J Biol Chem. 2008 Nov 7;283(45):31125-32.
38. Bowie AG, Unterholzner L. Viral evasion and subversion of patternrecognition receptor signalling. Nat Rev Immunol. 2008 Dec;8(12):911-22.
39. Ribeiro A, Wornle M, Motamedi N, et al. Activation of innate immune defense mechanisms contributes to polyomavirus BK-associated nephropathy. Kidney Int. 2011 Sep 14.
40. Abend JR, Low JA, Imperiale MJ. Global effects of BKV infection on gene expression in human primary kidney epithelial cells. Virology. 2010 Feb 5;397(1):73-9.
41. Grinde B, Gayorfar M, Rinaldo CH. Impact of a polyomavirus (BKV) infection on mRNA expression in human endothelial cells. Virus Res. 2007 Jan;123(1):86-94.
42. Mueller K, Schachtner T, Sattler A, et al. BK-VP3 as a new target of cellular immunity in BK virus infection. Transplantation. 2011 Jan 15;91(1):100-7.
43. Schachtner T, Muller K, Stein M, et al. BKV-Specific Immunity Kinetics: A Predictor of Recovery From Polyomavirus BK-Associated Nephropathy. Am J Transplant. 2011 Aug 10.
44. Chen Y, Trofe J, Gordon J, et al. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J Virol. 2006 Apr;80(7):3495-505.
45. Sharma MC, Zhou W, Martinez J, et al. Cross-reactive CTL recognizing two HLA-A*02-restricted epitopes within the BK virus and JC virus VP1 polypeptides are frequent in immunocompetent individuals. Virology. 2006 Jun 20;350(1):128-36.
46. Krymskaya L, Sharma MC, Martinez J, et al. Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides. J Virol. 2005 Sep;79(17):11170-8.
47. Li J, Melenhorst J, Hensel N, Rezvani K, et al. T-cell responses to peptide fragments of the BK virus T antigen: implications for cross-reactivity of immune response to JC virus. J Gen Virol. 2006 Oct;87(Pt 10):2951-60.
48. Leuenberger D, Andresen PA, Gosert R, et al. Human polyomavirus type 1 (BK virus) agnoprotein is abundantly expressed but immunologically ignored. Clin Vaccine Immunol. 2007 Aug;14(8):959-68.
49. Binggeli S, Egli A, Schaub S, et al. Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients. Am J Transplant. 2007 May;7(5):1131-9.
50. Blyth E, Clancy L, Simms R, et al. BK Virus-Specific T Cells for Use in Cellular Therapy Show Specificity to Multiple Antigens and Polyfunctional Cytokine Responses. Transplantation. 2011 Nov 27;92(10):1077-84.
51. Trydzenskaya H, Sattler A, Muller K, et al. Novel approach for improved assessment of phenotypic and functional characteristics of BKV-specific T-cell immunity. Transplantation. 2011 Dec 15;92(11):1269-77.
52. Zhou W, Sharma M, Martinez J, et al. Functional characterization of BK virus-specific CD4+ T cells with cytotoxic potential in seropositive adults. Viral Immunol. 2007 Sep;20(3):379-88.
53. Ramaswami B, Popescu I, Macedo C, et al. The polyomavirus BK large T-antigen-derived peptide elicits an HLA-DR promiscuous and polyfunctional CD4+ T-cell response. Clin Vaccine Immunol. 2011 May;18(5):815-24.
54. Provenzano M, Bracci L, Wyler S, et al. Characterization of highly frequent epitope-specific CD45RA+/CCR7+/-T lymphocyte responses against p53-binding domains of the human polyomavirus BK large tumor antigen in HLA-A*0201+ BKV-seropositive donors. J Transl Med. 2006;4:47.
55. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med. 2002 Aug 15;347(7):488-96.
56. Bogdanovic G, Priftakis P, Taemmeraes B, et al. Primary BK virus (BKV) infection due to possible BKV transmission during bone marrow transplantation is not the major cause of hemorrhagic cystitis in transplanted children. Pediatr Transplant. 1998 Nov;2(4):288-93.
57. Bohl DL, Brennan DC, Ryschkewitsch C, Gaudreault-Keener M, Major EO, Storch GA. BK virus antibody titers and intensity of infections after renal transplantation. J Clin Virol. 2008 Oct;43(2):184-9.
58. Ginevri F, De SR, Comoli P, et al. Polyomavirus BK infection in pediatric kidney-allograft recipients: a single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation. 2003 Apr 27;75(8):1266-70.
59. Smith JM, McDonald RA, Finn LS, Healey PJ, Davis CL, Limaye AP. Polyomavirus nephropathy in pediatric kidney transplant recipients. Am J Transplant. 2004 Dec;4(12):2109-17.
60. Rosen S, Harmon W, Krensky AM, et al. Tubulo-interstitial nephritis associated with polyomavirus (BK type) infection. N Engl J Med. 1983 May 19;308(20):1192-6.
61. Bauman Y, Nachmani D, Vitenshtein A, et al. An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination. Cell Host Microbe. 2011 Feb 17;9(2):93-102.
62. Sullivan CS, Grundhoff AT, Tevethia S, Pipas JM, Ganem D. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature. 2005 Jun 2;435(7042):682-6.
63. Randhawa PS, Khaleel-Ur-Rehman K, Swalsky PA, et al. DNA sequencing of viral capsid protein VP-1 region in patients with BK virus interstitial nephritis. Transplantation. 2002 Apr 15;73(7):1090-4.
64. Luo C, Hirsch HH, Kant J, Randhawa P. VP-1 quasispecies in human infection with polyomavirus BK. J Med Virol. 2012 Jan;84(1):152-61.
65. Comar M, Bonifacio D, Zanconati F, et al. High prevalence of BK polyomavirus sequences in human papillomavirus-16-positive precancerous cervical lesions. J Med Virol. 2011 Oct;83(10):1770-6.
66. Dorries K, Vogel E, Gunther S, Czub S. Infection of human polyomaviruses JC and BK in peripheral blood leukocytes from immunocompetent individuals. Virology. 1994 Jan;198(1):59-70.
67. Zambrano A, Kalantari M, Simoneau A, Jensen JL, Villarreal LP. Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections. Prostate. 2002 Dec 1;53(4):263-76.
68. Saitoh K, Sugae N, Koike N, Akiyama Y, Iwamura Y, Kimura H. Diagnosis of childhood BK virus cystitis by electron microscopy and PCR. J Clin Pathol. 1993 Aug;46(8):773-5.
69. Egli A, Infanti L, Dumoulin A, et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis. 2009 Mar 15;199(6):837-46.
70. Lesprit P, Chaline-Lehmann D, Authier FJ, Ponnelle T, Gray F, Levy Y. BK virus encephalitis in a patient with AIDS and lymphoma. AIDS. 2001 Jun 15;15(9):1196-9.
71. Hedquist BG, Bratt G, Hammarin AL, et al. Identification of BK virus in a patient with acquired immune deficiency syndrome and bilateral atypical retinitis. Ophthalmology. 1999 Jan;106(1):129-32.
72. Vallbracht A, Lohler J, Gossmann J, et al. Disseminated BK type polyomavirus infection in an AIDS patient associated with central nervous system disease. Am J Pathol. 1993 Jul;143(1):29-39.
73. Petrogiannis-Haliotis T, Sakoulas G, Kirby J, et al. BK-related polyomavirus vasculopathy in a renal-transplant recipient. N Engl J Med. 2001 Oct 25;345(17):1250-5.
74. Schaub S, Hirsch HH, Dickenmann M, et al. Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy. Am J Transplant. 2010 Dec;10(12):2615-23.
75. Viscount HB, Eid AJ, Espy MJ, et al. Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy. Transplantation. 2007 Aug 15;84(3):340-5.
76. Verghese PS, Finn LS, Englund JA, Sanders JE, Hingorani SR. BK nephropathy in pediatric hematopoietic stem cell transplant recipients. Pediatr Transplant. 2009 Nov;13(7):913-8.
77. Egli A, Helmersen DS, Taub K, Hirsch HH, Johnson A. Renal failure five years after lung transplantation due to polyomavirus BK-associated nephropathy. Am J Transplant. 2010 Oct;10(10):2324-30.
78. Menahem SA, McDougall KM, Thomson NM, Dowling JP. Native kidney BK nephropathy post cardiac transplantation. Transplantation. 2005 Jan 27;79(2):259-60.
79. Bratt G, Hammarin AL, Grandien M, et al. BK virus as the cause of meningoencephalitis, retinitis and nephritis in a patient with AIDS. AIDS. 1999 Jun 18;13(9):1071-5.
80. Smith JM, Dharnidharka VR, Talley L, Martz K, McDonald RA. BK virus nephropathy in pediatric renal transplant recipients: an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry. Clin J Am Soc Nephrol. 2007 Sep;2(5):1037-42.
81. Namba Y, Moriyama T, Kyo M, et al. Prevalence, characteristics, and outcome of BK virus nephropathy in Japanese renal transplant patients: analysis in protocol and episode biopsies. Clin Transplant. 2005 Feb;19(1):97-101.
82. Mengel M, Marwedel M, Radermacher J, et al. Incidence of polyomavirusnephropathy in renal allografts: influence of modern immunosuppressive drugs. Nephrol Dial Transplant. 2003 Jun;18(6):1190-6.
83. Geddes CC, Gunson R, Mazonakis E, et al. BK viremia surveillance after kidney transplant: single-center experience during a change from cyclosporine-to lower-dose tacrolimus-based primary immunosuppression regimen. Transpl Infect Dis. 2011 Apr;13(2):109-16.
84. Barri YM, Ahmad I, Ketel BL, et al. Polyoma viral infection in renal transplantation: the role of immunosuppressive therapy. Clin Transplant. 2001 Aug;15(4):240-6.
85. Binet I, Nickeleit V, Hirsch HH, et al. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation. 1999 Mar 27;67(6):918-22.
86. Atencio IA, Shadan FF, Zhou XJ, Vaziri ND, Villarreal LP. Adult mouse kidneys become permissive to acute polyomavirus infection and reactivate persistent infections in response to cellular damage and regeneration. J Virol. 1993 Mar;67(3):1424-32.
87. Priftakis P, Bogdanovic G, Tyden G, Dalianis T. Polyomaviruria in renal transplant patients is not correlated to the cold ischemia period or to rejection episodes. J Clin Microbiol. 2000 Jan;38(1):406-7.
88. Bressollette-Bodin C, Coste-Burel M, Hourmant M, Sebille V, Andre-Garnier E, Imbert-Marcille BM. A prospective longitudinal study of BK virus infection in 104 renal transplant recipients. Am J Transplant. 2005 Aug;5(8):1926-33.
89. Hammer MH, Brestrich G, Andree H, et al. HLA type-independent method to monitor polyoma BK virus-specific CD4 and CD8 T-cell immunity. Am J Transplant. 2006 Mar;6(3):625-31.
90. Han Lee ED, Kemball CC, Wang J, et al. A mouse model for polyomavirusassociated nephropathy of kidney transplants. Am J Transplant. 2006 May;6(5 Pt 1):913-22.
91. Bressollette-Bodin C, Coste-Burel M, Hourmant M, Sebille V, Andre-Garnier E, Imbert-Marcille BM. A prospective longitudinal study of BK virus infection in 104 renal transplant recipients. Am J Transplant. 2005 Aug;5(8):1926-33.
92. Ramos E, Drachenberg CB, Papadimitriou JC, et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol. 2002 Aug;13(8):2145-51.
93. Awadalla Y, Randhawa P, Ruppert K, Zeevi A, Duquesnoy RJ. HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients. Am J Transplant. 2004 Oct;4(10):1691-6.
94. Babel N, Fendt J, Karaivanov S, et al. Sustained BK viruria as an early marker for the development of BKV-associated nephropathy: analysis of 4128 urine and serum samples. Transplantation. 2009 Jul 15;88(1):89-95.
95. Mindlova M, Boucek P, Saudek F, et al. Prevalence and risk factors of polyomavirus BK replication in simultaneous pancreas/kidney transplant recipients from a single transplant center. Clin Transplant. 2012;26:267-74.
96. Girmanova E, Brabcova I, Bandur S, Hribova P, Skibova J, Viklicky O. A prospective longitudinal study of BK virus infection in 120 Czech renal transplant recipients. J Med Virol. 2011 Aug;83(8):1395-400.
97. Vasudev B, Hariharan S, Hussain SA, Zhu YR, Bresnahan BA, Cohen EP. BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients. Kidney Int. 2005 Oct;68(4):1834-9.
98. Alexander RT, Langlois V, Tellier R, Robinson L, Hebert D. The prevalence of BK viremia and urinary viral shedding in a pediatric renal transplant population: a single-center retrospective analysis. Pediatr Transplant. 2006 Aug;10(5):586-92.
99. Bohl DL, Storch GA, Ryschkewitsch C, et al. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am J Transplant. 2005 Sep;5(9):2213-21.
100. Nukuzuma S, Takasaka T, Zheng HY, et al. Subtype I BK polyomavirus strains grow more efficiently in human renal epithelial cells than subtype IV strains. J Gen Virol. 2006 Jul;87(Pt 7):1893-901.
101. Olsen GH, Hirsch HH, Rinaldo CH. Functional analysis of polyomavirus BK non-coding control region quasispecies from kidney transplant recipients. J Med Virol. 2009 Nov;81(11):1959-67.
102. Gosert R, Rinaldo CH, Funk GA, et al. Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology. J Exp Med. 2008 Apr 14;205(4):841-52.
103. Herman J, Van RM, Snoeck R, Beuselinck K, Lerut E, Van Damme-Lombaerts R. Polyomavirus infection in pediatric renal transplant recipients: evaluation using a quantitative real-time PCR technique. Pediatr Transplant. 2004 Oct;8(5):485-92.
104. Huang G, Chen LZ, Qiu J, et al. Prospective study of polyomavirus BK replication and nephropathy in renal transplant recipients in China: a single-center analysis of incidence, reduction in immunosuppression and clinical course. Clin Transplant. 2010 Sep;24(5):599-609.
105. Singh HK, Andreoni KA, Madden V, et al. Presence of urinary Haufen accurately predicts polyomavirus nephropathy. J Am Soc Nephrol. 2009 Feb;20(2):416-27.
106. Almeras C, Foulongne V, Garrigue V, et al. Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study. Transplantation. 2008 Apr 27;85(8):1099-104.
107. Drachenberg CB, Hirsch HH, Ramos E, Papadimitriou JC. Polyomavirus disease in renal transplantation: review of pathological findings and diagnostic methods. Hum Pathol. 2005 Dec;36(12):1245-55.
108. Randhawa PS, Finkelstein S, Scantlebury V, et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation. 1999 Jan 15;67(1):103-9.
109. Almeras C, Vetromile F, Garrigue V, Szwarc I, Foulongne V, Mourad G. Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients. Transpl Infect Dis. 2011 Apr;13(2):101-8.
110. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant. 2005 Mar;5(3):582-94.
111. Egli A, Kohli S, Dickenmann M, Hirsch HH. Inhibition of polyomavirus BK-specific T-Cell responses by immunosuppressive drugs. Transplantation. 2009 Nov 27;88(10):1161-8.
112. Liacini A, Seamone ME, Muruve DA, Tibbles LA. Anti-BK virus mechanisms of sirolimus and leflunomide alone and in combination: toward a new therapy for BK virus infection. Transplantation. 2010 Dec 27;90(12):1450-7.
113. Tedesco SH, Jr., Cibrik D, Johnston T, et al. Everolimus plus reducedexposure CsA versus mycophenolic acid plus standard-exposure CsA in renal-transplant recipients. Am J Transplant. 2010 Jun;10(6):1401-13.
114. Gralla J, Wiseman AC. Tacrolimus/sirolimus versus tacrolimus/ mycophenolate in kidney transplantation: improved 3-year graft and patient survival in recent era. Transplantation. 2009 Jun 15;87(11):1712-9.
115. Wali RK, Drachenberg C, Hirsch HH, et al. BK virus-associated nephropathy in renal allograft recipients: rescue therapy by sirolimus-based immunosuppression. Transplantation. 2004 Oct 15;78(7):1069-73.
116. Benavides CA, Pollard VB, Mauiyyedi S, Podder H, Knight R, Kahan BD. BK virus-associated nephropathy in sirolimus-treated renal transplant patients: incidence, course, and clinical outcomes. Transplantation. 2007 Jul 15;84(1):83-8.
117. Andrei G, Snoeck R, Vandeputte M, et al. Activities of various compounds against murine and primate polyomaviruses. Antimicrob Agents Chemother. 1997 Mar;41(3):587-93.
118. Kuypers DR, Vandooren AK, Lerut E, et al. Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. Am J Transplant. 2005 Aug;5(8):1997-2004.
119. Kuypers DR, Bammens B, Claes K, Evenepoel P, Lerut E, Vanrenterghem Y. A single-centre study of adjuvant cidofovir therapy for BK virus interstitial nephritis (BKVIN) in renal allograft recipients. J Antimicrob Chemother. 2009 Feb;63(2):417-9.
120. Araya CE, Lew JF, Fennell RS, III, Neiberger RE, Dharnidharka VR. Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy. Pediatr Transplant. 2006 Feb;10(1):32-7.
121. Araya CE, Lew JF, Fennell RS, Neiberger RE, Dharnidharka VR. Intermediate dose cidofovir does not cause additive nephrotoxicity in BK virus allograft nephropathy. Pediatr Transplant. 2008 Nov;12(7):790-5.
122. Sener A, House AA, Jevnikar AM, et al. Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: one-year follow-up of renal allograft recipients. Transplantation. 2006 Jan 15;81(1):117-20.
123. Randhawa PS, Schonder K, Shapiro R, Farasati N, Huang Y. Polyomavirus BK neutralizing activity in human immunoglobulin preparations. Transplantation. 2010 Jun 27;89(12):1462-5.
124. Maggiore U, Medici MC, Vaglio A, Buzio C. Increased viral load after intravenous immunoglobulin therapy for BK virus-associated nephropathy. Transpl Infect Dis. 2010 Oct;12(5):470-2.
125. Williams JW, Javaid B, Kadambi PV, et al. Leflunomide for polyomavirus type BK nephropathy. N Engl J Med. 2005 Mar 17;352(11):1157-8.
126. Josephson MA, Gillen D, Javaid B, et al. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation. 2006 Mar 15;81(5):704-10.
127. Faguer S, Hirsch HH, Kamar N, et al. Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation. Transpl Int. 2007 Nov;20(11):962-9.
128. Leca N, Muczynski KA, Jefferson JA, et al. Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients. Clin J Am Soc Nephrol. 2008 May;3(3):829-35.
129. Bernhoff E, Tylden GD, Kjerpeseth LJ, Gutteberg TJ, Hirsch HH, Rinaldo CH. Leflunomide inhibition of BK virus replication in renal tubular epithelial cells. J Virol. 2010 Feb;84(4):2150-6.
130. Gabardi S, Waikar SS, Martin S, et al. Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation. Clin J Am Soc Nephrol. 2010 Jul;5(7):1298-304.
131. Sharma BN, Li R, Bernhoff E, Gutteberg TJ, Rinaldo CH. Fluoroquinolones inhibit human polyomavirus BK (BKV) replication in primary human kidney cells. Antiviral Res. 2011 Oct;92(1):115-23.
132. Koukoulaki M, Apostolou T, Hadjiconstantinou V, Drakopoulos S. Impact of prophylactic administration of ciprofloxacin on BK polyoma virus replication. Transpl Infect Dis. 2008 Dec;10(6):449-51.
133. Moriyama T, Sorokin A. Repression of BK virus infection of human renal proximal tubular epithelial cells by pravastatin. Transplantation. 2008 May 15;85(9):1311-7.
134. Coleman DV, Mackenzie EF, Gardner SD, Poulding JM, Amer B, Russell WJ. Human polyomavirus (BK) infection and ureteric stenosis in renal allograft recipients. J Clin Pathol. 1978 Apr;31(4):338-47.
135. Mackenzie EF, Poulding JM, Harrison PR, Amer B. Human polyoma virus (HPV)--a significant pathogen in renal transplantation. Proc Eur Dial Transplant Assoc. 1978;15:352-60.
136. Gardner SD, MacKenzie EF, Smith C, Porter AA. Prospective study of the human polyomaviruses BK and JC and cytomegalovirus in renal transplant recipients. J Clin Pathol. 1984 May;37(5):578-86.
137. Khan H, Oberoi S, Mahvash A, et al. Reversible ureteral obstruction due to polyomavirus infection after percutaneous nephrostomy catheter placement. Biol Blood Marrow Transplant. 2011 Oct;17(10):1551-5.
138. Gorczynska E, Turkiewicz D, Rybka K, et al. Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2005 Oct;11(10):797-804.
139. O'Donnell PH, Swanson K, Josephson MA, et al. BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoetic stem cell transplants. Biol Blood Marrow Transplant. 2009 Sep;15(9):1038-48.
140. Gaziev J, Paba P, Miano R, et al. Late-onset hemorrhagic cystitis in children after hematopoietic stem cell transplantation for thalassemia and sickle cell anemia: a prospective evaluation of polyoma (BK) virus infection and treatment with cidofovir. Biol Blood Marrow Transplant. 2010 May;16(5):662-71.
141. Wong AS, Chan KH, Cheng VC, Yuen KY, Kwong YL, Leung AY. Relationship of pretransplantation polyoma BK virus serologic findings and BK viral reactivation after hematopoietic stem cell transplantation. Clin Infect Dis. 2007 Mar 15;44(6):830-7.
142. Leung AY, Suen CK, Lie AK, Liang RH, Yuen KY, Kwong YL. Quantification of polyoma BK viruria in hemorrhagic cystitis complicating bone marrow transplantation. Blood. 2001 Sep 15;98(6):1971-8.
143. Koc S, Hagglund H, Ireton RC, Perez-Simon JA, Collins SJ, Appelbaum FR. Successful treatment of severe hemorrhagic cystitis with cystectomy following matched donor allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2000 Oct;26(8):899-901.
144. Garderet L, Bittencourt H, Sebe P, et al. Cystectomy for severe hemorrhagic cystitis in allogeneic stem cell transplant recipients. Transplantation. 2000 Dec 27;70(12):1807-11.
145. Silva LP, Patah PA, Saliba RM, et al. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type. Haematologica. 2010 Jul;95(7):1183-90.
146. Cesaro S, Facchin C, Tridello G, et al. A prospective study of BK-virusassociated haemorrhagic cystitis in paediatric patients undergoing allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant. 2008 Feb;41(4):363-70.
147. Haines HL, Laskin BL, Goebel J, et al. Blood, and not urine, BK viral load predicts renal outcome in children with hemorrhagic cystitis following hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2011 Oct;17(10):1512-9.
148. Giraud G, Priftakis P, Bogdanovic G, et al. BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLAmismatched grafts. Bone Marrow Transplant. 2008 Apr;41(8):737-42.
149. Giraud G, Bogdanovic G, Priftakis P, et al. The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimen. Haematologica. 2006 Mar;91(3):401-4.
150. Bogdanovic G, Priftakis P, Giraud G, et al. Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantation. J Clin Microbiol. 2004 Nov;42(11):5394-6.
151. Tanaka K, Hori T, Hatakeyama N, et al. Quantification of BK polyoma viruria in Japanese children and adults with hemorrhagic cystitis complicating stem cell transplantation. J Med Virol. 2008 Dec;80(12):2108-12.
152. Leung AY, Mak R, Lie AK, et al. Clinicopathological features and risk factors of clinically overt haemorrhagic cystitis complicating bone marrow transplantation. Bone Marrow Transplant. 2002 Mar;29(6):509-13.
153. Mori Y, Miyamoto T, Kato K, et al. Different Risk Factors Related to Adenovirus- or BK Virus-Associated Hemorrhagic Cystitis following Allogeneic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2012 Mar;18(3):458-65.
154. Priftakis P, Bogdanovic G, Kalantari M, Dalianis T. Overrepresentation of point mutations in the Sp1 site of the non-coding control region of BK virus in bone marrow transplanted patients with haemorrhagic cystitis. J Clin Virol. 2001 Apr;21(1):1-7.
155. Bridges B, Donegan S, Badros A. Cidofovir bladder instillation for the treatment of BK hemorrhagic cystitis after allogeneic stem cell transplantation. Am J Hematol. 2006 Jul;81(7):535-7.
156. Peinemann F, de Villiers EM, Dorries K, Adams O, Vogeli TA, Burdach S. Clinical course and treatment of haemorrhagic cystitis associated with BK type of human polyomavirus in nine paediatric recipients of allogeneic bone marrow transplants. Eur J Pediatr. 2000 Mar;159(3):182-8.
157. Cesaro S, Brugiolo A, Faraci M, et al. Incidence and treatment of hemorrhagic cystitis in children given hematopoietic stem cell transplantation: a survey from the Italian association of pediatric hematology oncology-bone marrow transplantation group. Bone Marrow Transplant. 2003 Nov;32(9):925-31.
158. Miller AN, Glode A, Hogan KR, et al. Efficacy and safety of ciprofloxacin for prophylaxis of polyomavirus BK virus-associated hemorrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant. 2011 Aug;17(8):1176-81.
159. Leung AY, Chan MT, Yuen KY, et al. Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. Clin Infect Dis. 2005 Feb 15;40(4):528-37.
160. Harkensee C, Vasdev N, Gennery AR, Willetts IE, Taylor C. Prevention and management of BK-virus associated haemorrhagic cystitis in children following haematopoietic stem cell transplantation--a systematic review and evidence-based guidance for clinical management. Br J Haematol. 2008 Sep;142(5):717-31.
161. Corallini A, Pagnani M, Viadana P, et al. Association of BK virus with human brain tumors and tumors of pancreatic islets. Int J Cancer. 1987 Jan 15;39(1):60-7.
162. Fiori M, di MG. Occurrence of BK virus DNA in DNA obtained from certain human tumors. Proc Natl Acad Sci U S A. 1976 Dec;73(12):4662-6.
163. Dorries K, Loeber G, Meixensberger J. Association of polyomaviruses JC, SV40, and BK with human brain tumors. Virology. 1987 Sep;160(1):268-70.
164. Das D, Wojno K, Imperiale MJ. BK virus as a cofactor in the etiology of prostate cancer in its early stages. J Virol. 2008 Mar;82(6):2705-14.
165. Weinreb DB, Desman GT, Amolat-Apiado MJ, Burstein DE, Godbold JH, Jr., Johnson EM. Polyoma virus infection is a prominent risk factor for bladder carcinoma in immunocompetent individuals. Diagn Cytopathol. 2006 Mar;34(3):201-3.
166. Monini P, Rotola A, Di Luca D, et al. Latent BK virus infection and Kaposi'ssarcoma pathogenesis. Int J Cancer. 1996 Jun 11;66(6):717-22.
167. Negrini M, Rimessi P, Mantovani C, et al. Characterization of BK virus variants rescued from human tumours and tumour cell lines. J Gen Virol. 1990 Nov;71 (Pt 11):2731-6.
168. De Mattei M, Martini F, Corallini A, et al. High incidence of BK virus large-T-antigen-coding sequences in normal human tissues and tumors of different histotypes. Int J Cancer. 1995 Jun 9;61(6):756-60.
169. Narayanan M, Szymanski J, Slavcheva E, et al. BK virus associated renal cell carcinoma: case presentation with optimized PCR and other diagnostic tests. Am J Transplant. 2007 Jun;7(6):1666-71.
170. Geetha D, Tong BC, Racusen L, Markowitz JS, Westra WH. Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent. Transplantation. 2002 Jun 27;73(12):1933-6.
171. Rollison DE, Sexton WJ, Rodriguez AR, Kang LC, Daniel R, Shah KV. Lack of BK virus DNA sequences in most transitional-cell carcinomas of the bladder. Int J Cancer. 2007 Mar 15;120(6):1248-51.
172. Grossi MP, Meneguzzi G, Chenciner N, et al. Lack of association between BK virus and ependymomas, malignant tumors of pancreatic islets, osteosarcomas and other human tumors. Intervirology. 1981;15(1):10-7.
173. Greenlee JE, Becker LE, Narayan O, Johnson RT. Failure to demonstrate papovavirus tumor antigen in human cerebral neoplasms. Ann Neurol. 1978 Jun;3(6):479-81.
174. Becker LE, Narayan O, Johnson RT. Studies of human papovavirus tumor antigen in experimental and human cerebral neoplasms. Can J Neurol Sci. 1976 May;3(2):105-9.
175. Wold WS, Mackey JK, Brackmann KH, Takemori N, Rigden P, Green M. Analysis of human tumors and human malignant cell lines for BK virus-specific DNA sequences. Proc Natl Acad Sci U S A. 1978 Jan;75(1):454-8.
176. Israel MA, Martin MA, Takemoto KK, et al. Evaluation of normal and neoplastic human tissue for BK virus. Virology. 1978 Oct 15;90(2):187-96.
177. Ibelgaufts H, Jones KW. Papovavirus-related RNA sequences in human neurogenic tumours. Acta Neuropathol. 1982;56(2):118-22.
178. Arthur RR, Grossman SA, Ronnett BM, Bigner SH, Vogelstein B, Shah KV. Lack of association of human polyomaviruses with human brain tumors. J Neurooncol. 1994;20(1):55-8.
179. Volter C, Hausen H, Alber D, de Villiers EM. Screening human tumor samples with a broad-spectrum polymerase chain reaction method for the detection of polyomaviruses. Virology. 1997 Oct 27;237(2):389-96.
180. Major EO, di Mayorca G. Malignant transformation of BHK21 clone 13 cells by BK virus--a human papovavirus. Proc Natl Acad Sci U S A. 1973 Nov;70(11):3210-2.
181. Takemoto KK, Martin MA. Transformation of hamster kidney cells by BK papovavirus DNA. J Virol. 1975 Jan;17(1):247-53.
182. Dalrymple SA, Beemon KL. BK virus T antigens induce kidney carcinomas and thymoproliferative disorders in transgenic mice. J Virol. 1990 Mar;64(3):1182-91.
183. Portolani M, Borgatti M. Stable transformation of mouse, rabbit and monkey cells and abortive transformation of human cells by BK virus, a human papovavirus. J Gen Virol. 1978 Feb;38(2):369-74.
184. Shah KV, Hudson C, Valis J, Strandberg JD. Experimental infection of human foreskin cultures with BK virus, a human papovavirus. Proc Soc Exp Biol Med. 1976 Oct;153(1):180-6.
185. Sabbioni S, Negrini M, Possati L, et al. Multiple loci on human chromosome 11 control tumorigenicity of BK virus transformed cells. Int J Cancer. 1994 Apr 15;57(2):185-91.
186. Monini P, Rotola A, Di Luca D, et al. DNA rearrangements impairing BK virus productive infection in urinary tract tumors. Virology. 1995 Dec 1;214(1):273-9.
187. Watanabe S, Yoshiike K, Nozawa A, Yuasa Y, Uchida S. Viable deletion mutant of human papovavirus BK that induces insulinomas in hamsters. J Virol. 1979 Dec;32(3):934-42.
188. Watanabe S, Yogo Y, Yoshiike K. Expression of viral early functions in rat 3Y1 cells infected with human papovavirus BK. J Virol. 1984 Jan;49(1):78-85.
189. Johnsen JI, Seternes OM, Johansen T, Moens U, Mantyjarvi R, Traavik T. Subpopulations of non-coding control region variants within a cell culture-passaged stock of BK virus: sequence comparisons and biological characteristics. J Gen Virol. 1995 Jul;76 (Pt 7):1571-81.
190. Abend JR, Jiang M, Imperiale MJ. BK virus and human cancer: innocent until proven guilty. Semin Cancer Biol. 2009 Aug;19(4):252-60.